Gimsilumab

  1. Home
  2. Posts tagged “Gimsilumab”
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.
By MediSys Research Admin
May 29, 2020
90 Views
Clinical Trials

Kinevant Sciences GmbH, KIN-1901-2001

Recent Posts
Chasing the Dragon
November 3, 2022
Metagenomic Sequencing of the Gallbladder Microbiome: Bacterial Diversity Does Not Vary by Surgical Pathology
October 27, 2022
The patient behind the wound assessment and plan
October 27, 2022
Physiology, Central Venous Pressure
October 27, 2022
A feeding jejunostomy causing an intussusception - case report and literature review
October 27, 2022
Neuroleptic Malignant Syndrome From Oxcarbazepine and Topiramate Withdrawal: An Unusual Case
October 27, 2022
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Neuropsychiatric and Multidisciplinary Approach to a Patient Not Responding to First-Line Treatment
October 27, 2022
A False-Negative Pregnancy Test in an Adolescent
October 27, 2022
Autogenous iliac crest bone grafting for tibial nonunions revisited: does approach matter?
October 27, 2022
Quality differences in multifragmentary pertrochanteric fractures [OTA 31A2.2 and 31A2.3] treated with short and long cephalomedullary nails
October 27, 2022